TY  - GEN
AU  - Mousseau,Yoanne
AU  - Mollard,Séverine
AU  - Faucher-Durand,Karine
AU  - Richard,Laurence
AU  - Nizou,Angélique
AU  - Cook-Moreau,Jeanne
AU  - Baaj,Yasser
AU  - Qiu,Hao
AU  - Plainard,Xavier
AU  - Fourcade,Laurent
AU  - Funalot,Benoit
AU  - Sturtz,Franck G
TI  - Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model
SN  - 1573-7217
PY  - 2012///1119
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Aorta, Thoracic
KW  - pathology
KW  - Carcinoma 256, Walker
KW  - blood supply
KW  - Cell Movement
KW  - Cells, Cultured
KW  - Drug Screening Assays, Antitumor
KW  - Drug Synergism
KW  - Female
KW  - Fingolimod Hydrochloride
KW  - Indoles
KW  - administration & dosage
KW  - Male
KW  - Mammary Neoplasms, Experimental
KW  - Myocytes, Smooth Muscle
KW  - drug effects
KW  - Neoplasm Transplantation
KW  - Propylene Glycols
KW  - Proto-Oncogene Proteins c-sis
KW  - Pyrroles
KW  - Rats
KW  - Rats, Sprague-Dawley
KW  - Receptor, Platelet-Derived Growth Factor beta
KW  - antagonists & inhibitors
KW  - Receptors, Lysosphingolipid
KW  - metabolism
KW  - Sphingosine
KW  - Sphingosine-1-Phosphate Receptors
KW  - Statistics, Nonparametric
KW  - Sunitinib
KW  - Tumor Burden
KW  - Tyrphostins
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10549-011-1903-6
ER  -